Clinical Trial Results: Positive trial outcomes often lead to significant stock price increases, while negative results can cause substantial declines.

Regulatory Decisions: FDA approvals or rejections of NWBO's treatments directly impact investor confidence and stock value.

Financial Performance: The company's cash position, revenue, and profitability affect investor perception of its long-term viability.

Market Sentiment: Overall market trends and investor optimism or pessimism regarding the biotechnology sector can influence NWBO's stock price.

Competition: The emergence of competing therapies or companies in the same market can impact NWBO's perceived market share and future revenue.

News and Announcements: Company-specific news, such as partnerships, acquisitions, or management changes, can trigger price fluctuations.

Trading Volume: High trading volume can indicate increased investor interest and potential price volatility.

Analyst Ratings: Recommendations from financial analysts can influence investor decisions and affect the stock price.

Economic Conditions: Broader economic factors, such as interest rates and inflation, can indirectly impact investor sentiment and investment decisions.

Patent Protection: The strength and duration of NWBO's patents protect their product exclusivity and drive investment decisions.